SISTEMA INTEGRAL DE INFORMACIÓN ACADÉMICA - PÚBLICO

Martinez-Guerra B.A.
(Autor externo)

Obras con ISBN:0
Documentos en revistas:20
Colaboraciones en Tesis:0
Patentes:0
Obras con ISBN:No hay obras de este autor.
Documentos en revistas:
1.- Phylogenomic and phenotypic profiling of carbapenem-resistant Pseudomonas aeruginosa clinical isolates reveals lineage-specific resistance mechanisms and adaptive responses (2026)
 
2.- The threat of multidrug-resistant microorganisms: active surveillance of key antimicrobial resistant pathogens in 2025 - a report from the INVIFAR network (2026)
 
3.- Author Correction: Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990?2023: a Global Burden of Disease study (Nature Medicine, (2026), 32, 1, (197-223), 10.1038/s41591-025-04077-9) (2026)
 
4.- The ongoing antibiotic resistance and carbapenemase encoding genotypes surveillance. The first quarter report of the INVIFAR network for 2024. (2025)
 
5.- Recommended antibiotic treatment agreement between infectious diseases specialists and ChatGPT® (2025)
 
6.- Global burden of bacterial antimicrobial resistance 1990?2021: a systematic analysis with forecasts to 2050 (2024)
 
7.- Global, regional, and national burden of HIV/AIDS, 1990?2021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021 (2024)
 
8.- Evaluation of the BD Phoenix Carbapenemase-Producing Organism Panels for the Detection of Carbapenemase Producers in Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa (2023)
 
9.- Active Surveillance of Antimicrobial Resistance and Carbapenemase-Encoding Genes According to Sites of Care and Age Groups in Mexico: Results from the INVIFAR Network (2023)
 
10.- Outcomes in Temporary ICUs Versus Conventional ICUs: An Observational Cohort of Mechanically Ventilated Patients With COVID-19-Induced Acute Respiratory Distress Syndrome (2022)
 
11.- Large scale screening for SARS-CoV-2 among healthcare workers: Prevalence and risk factors for asymptomatic/pauci-symptomatic carriers, with emphasis on PPE use (2022)
 
12.- Effect of Tocilizumab in Mortality among Patients with Severe and Critical Covid-19: Experience in a Third-Level Medical Center (2022)
 
13.- Outcomes of patients with severe and critical COVID-19 treated with dexamethasone: a prospective cohort study (2022)
 
14.- Adaptive Metabolic and Inflammatory Responses Identified Using Accelerated Aging Metrics Are Linked to Adverse Outcomes in Severe SARS-CoV-2 Infection (2021)
 
15.- Low Thoracic Skeletal Muscle Area Is Not Associated With Negative Outcomes in Patients With COVID-19 (2021)
 
16.- Antimicrobial resistance patterns and antibiotic use during hospital conversion in the COVID-19 pandemic (2021)
 
17.- Adverse Effects Associated With the Use of Antimalarials During The COVID-19 Pandemic in a Tertiary Care Center in Mexico City (2021)
 
18.- CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS OF PATIENTS DIAGNOSED WITH COVID-19 IN A TERTIARY CARE CENTER IN MEXICO CITY: A PROSPECTIVE COHORT STUDY (2020)
 
19.- Changes in Radial Artery Pulse Pressure During a Fluid Challenge Cannot Assess Fluid Responsiveness in Patients With Septic Shock (2020)
 
20.- Erratum: CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS OF PATIENTS DIAGNOSED WITH COVID-19 IN A TERTIARY CARE CENTER IN MEXICO CITY: A PROSPECTIVE COHORT STUDY (Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion (2020) 72 3 (165-177)) (2020)
 
Colaboraciones en Tesis:No hay tesis de este autor.
Patentes:No hay patentes de este autor.